Inflammation is a critical component in understanding how our bodies respond to and heal under various conditions. Recent research supports that inflammation may be the culprit to many chronic conditions including, bone health, joint health, cardiovascular health, and general well-being. Inflammation is driven by key mediators such as interleukin-1 and -6 which provide key signaling cues that drive the catabolic (breaking down) processes resulting in edema (swelling) and pain in tissues. On a cellular level, the inflammation response is governed by two distinct, yet overlapping signaling pathways, known as the Mitogen Activated Protein Kinases (MAPK) and SMAD pathways. Through a complex signaling cascade involve transmembrane, serine/threonine receptors, these pathways control the transcription and translation of key molecular drivers of inflammation. As such, these pathways represent an attractive target for inflammation control.
Researchers have shown that the bio-active proteins in Ostinol™ have a direct immuno-protective effect against IL-1 and Il-6. Ostinol works by binding to specific transmembrane receptors resulting in the propagation of an antagonistic signaling cue that leads to a decrease in the production and/or activation of pro-inflammatory signaling molecules. Thus the proteins within Ostinol protects the body by limiting the activity of pro-inflammatory cytokines, down-regulating the inflammation process at its root. By doing so, Ostinol™ helps our bodies control the inflammation pathways (and the associated pain) which results in a rapid clinical response and people feeling better fast – many in as fast as 7 days!